Skip to main content

LEMAITRE VASCULAR INC (LMAT) Stock Forecast 2025 - AI Price Prediction & Analysis


LEMAITRE VASCULAR INC (LMAT) AI Stock Price Forecast & Investment Analysis

LEMAITRE VASCULAR INC Stock Price Chart and Technical Analysis

Loading LEMAITRE VASCULAR INC interactive price chart and technical analysis...

LEMAITRE VASCULAR INC (LMAT) - Comprehensive Stock Analysis & Investment Research

Deep dive into LEMAITRE VASCULAR INC's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about LEMAITRE VASCULAR INC, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For LEMAITRE VASCULAR INC: LEMAITRE VASCULAR INC operates in the Industrial Applications and Services sector, establishing it as a mid-cap growth opportunity.

LEMAITRE VASCULAR INC (Stock Symbol: LMAT) is a leading company in the Industrial Applications and Services sector , specifically operating within the Surgical & Medical Instruments & Apparatus industry.

The organization employs approximately 411 professionals worldwide .

The company has established itself as a growing mid-cap opportunity with strong fundamentals.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing LEMAITRE VASCULAR INC's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For LEMAITRE VASCULAR INC: With $110M in annual revenue and 10.4% net margin, the company demonstrates solid profitability.

Annual Revenue: $110 million generating a 10.4% net profit margin .

Market Capitalization: $2043 million - Classified as a mid-cap growth stock with balanced risk-reward profile.

Return on Equity (ROE): 12.4% - Above-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for LEMAITRE VASCULAR INC stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For LEMAITRE VASCULAR INC: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for LEMAITRE VASCULAR INC stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: LEMAITRE VASCULAR INC's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For LEMAITRE VASCULAR INC: Strong free cash flow generation demonstrates developing operational efficiency.

LEMAITRE VASCULAR INC strategically competes in the highly dynamic Surgical & Medical Instruments & Apparatus marketplace, establishing itself as a promising mid-cap growth opportunity with strong fundamentals and expanding market share .

The company demonstrates robust operational efficiency through strong free cash flow generation of $29 million annually, complemented by impressive 145.4% year-over-year cash flow growth.

The company maintains a healthy 55.8% gross margin, indicating strong pricing power and operational efficiency.

LEMAITRE VASCULAR INC (LMAT) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for LEMAITRE VASCULAR INC stock analysis.

Loading LEMAITRE VASCULAR INC comprehensive fundamental analysis and insider trading data...

Deep dive into LEMAITRE VASCULAR INC's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if LEMAITRE VASCULAR INC stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For LEMAITRE VASCULAR INC: With a P/E ratio of 43.35, the market highly values future growth prospects.

P/E Ratio 43.35x
P/B Ratio 5.63x
Market Cap $2043M
Dividend Yield 0.81%
EPS $2.09
Book Value/Share $15.84
Revenue/Share $4.83
FCF/Share $1.13
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently LEMAITRE VASCULAR INC converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For LEMAITRE VASCULAR INC: An ROE of 12.4% shows good shareholder value creation.

ROE 12.4%
ROA 10.0%
ROIC 11.3%
Gross Margin 55.8%
Operating Margin 18.6%
Net Margin 10.4%
EBT Margin 22.0%
Tax Rate 22.4%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess LEMAITRE VASCULAR INC's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For LEMAITRE VASCULAR INC: A current ratio of 7.74 indicates strong liquidity.

Current Ratio 7.74x
Quick Ratio 5.05x
D/E Ratio 0.05x
Financial Leverage 1.13x
Interest Coverage 22.2x
Working Capital $69M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal LEMAITRE VASCULAR INC's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For LEMAITRE VASCULAR INC: Free cash flow of $29M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $34M
Free Cash Flow $29M
Capital Spending $-4M
OCF Growth YoY 145.4%
FCF Growth YoY 205.4%
FCF/Sales 18.6%
CapEx/Sales 2.8%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively LEMAITRE VASCULAR INC uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For LEMAITRE VASCULAR INC: An asset turnover of 0.59x suggests room for improvement in asset utilization.

Asset Turnover 0.59x
Receivables Turnover 7.6x
Inventory Turnover 1.4x
Fixed Assets Turnover 5.1x
Days Sales Outstanding 48 days
Days Inventory 270 days
Payables Period 16 days
Cash Conversion Cycle 302 days
Understanding Financial Statement Data

What these metrics mean: Key figures from LEMAITRE VASCULAR INC's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For LEMAITRE VASCULAR INC: With annual revenue of $110M, LEMAITRE VASCULAR INC demonstrates solid business size.

Income Statement ($ Millions)
Total Revenue $110M
R&D Expense $16M
SG&A Expense $35M
Cost of Goods Sold $67M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 48%
Cash & Short-term Investments 24%
Total Liabilities 12%
Short-term Debt 1%
Accounts Receivable 7%
Inventory 14%
Dividend & Shareholder Information
Dividends Per Share $0.72
Payout Ratio 0.3%
Shares Outstanding 23M
Growth Metrics (YoY)
EPS Growth 1.9%

Latest LEMAITRE VASCULAR INC Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting LEMAITRE VASCULAR INC (LMAT) stock price and investment outlook.

, source: Benzinga.com

LeMaitre Vascular LMAT will release its quarterly earnings report on Thursday, 2025-05-01. Here's a brief overview for investors ahead of the announcement. Analysts anticipate LeMaitre Vascular to ...

LEMAITRE VASCULAR INC Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of LEMAITRE VASCULAR INC against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ADGM Unlock Forecast - 30 Days FREE Trial $21M x 2.4x
ALUR Unlock Forecast - 30 Days FREE Trial $15M -0.4x -0.3x
ANGO Unlock Forecast - 30 Days FREE Trial $511M -1.4x 2.9x
ANIK Unlock Forecast - 30 Days FREE Trial $144M -4.3x 1.0x
AORT Unlock Forecast - 30 Days FREE Trial $1931M -198.2x 4.6x
APYX Unlock Forecast - 30 Days FREE Trial $116M -3.5x 16.1x
ARAY Unlock Forecast - 30 Days FREE Trial $177M -9.9x 2.2x
ATEC Unlock Forecast - 30 Days FREE Trial $2398M -7.4x 100.9x
ATRC Unlock Forecast - 30 Days FREE Trial $1865M -39.6x 4.0x
AVHHL Unlock Forecast - 30 Days FREE Trial $30M x x
BAX Unlock Forecast - 30 Days FREE Trial $11832M -94.9x 1.6x
BBNX Unlock Forecast - 30 Days FREE Trial $911M x 3.0x
BDX Unlock Forecast - 30 Days FREE Trial $53862M 34.1x 2.1x
BEAT Unlock Forecast - 30 Days FREE Trial $58M -5.7x 13.9x
BJDX Unlock Forecast - 30 Days FREE Trial $4M -0.5x 0.7x
BSX Unlock Forecast - 30 Days FREE Trial $151077M 61.0x 6.7x
BVS Unlock Forecast - 30 Days FREE Trial $477M -18.3x 3.0x
CARL Unlock Forecast - 30 Days FREE Trial $64M x x
CLPT Unlock Forecast - 30 Days FREE Trial $686M -23.5x 34.7x
CODX Unlock Forecast - 30 Days FREE Trial $12M -0.7x 0.3x
CVRX Unlock Forecast - 30 Days FREE Trial $273M -5.5x 4.7x
DCTH Unlock Forecast - 30 Days FREE Trial $358M 160.2x 3.4x
DRTS Unlock Forecast - 30 Days FREE Trial $344M x 4.0x
DXCM Unlock Forecast - 30 Days FREE Trial $28058M 49.1x 10.9x
EBRCZ Unlock Forecast - 30 Days FREE Trial $427M x 8.6x
FEMY Unlock Forecast - 30 Days FREE Trial $23M -1.4x 15.2x
FOFA Unlock Forecast - 30 Days FREE Trial $7M x 12.7x
GIPL Unlock Forecast - 30 Days FREE Trial $7M x 36.1x
GKOS Unlock Forecast - 30 Days FREE Trial $4275M -46.3x 5.6x
GMED Unlock Forecast - 30 Days FREE Trial $8605M 24.1x 2.0x
GUTS Unlock Forecast - 30 Days FREE Trial $69M x 13.8x
HRGN Unlock Forecast - 30 Days FREE Trial $29M x 38.2x
IART Unlock Forecast - 30 Days FREE Trial $1216M 200.2x 1.2x
ICCM Unlock Forecast - 30 Days FREE Trial $48M x 16.6x
ICUI Unlock Forecast - 30 Days FREE Trial $2969M -49.8x 1.4x
IDXG Unlock Forecast - 30 Days FREE Trial $4M 0.8x -0.9x
IINN Unlock Forecast - 30 Days FREE Trial $27M x 6.2x
IINNW Unlock Forecast - 30 Days FREE Trial $10M x 2.4x
INBS Unlock Forecast - 30 Days FREE Trial $8M -0.3x 2.7x
INFU Unlock Forecast - 30 Days FREE Trial $207M 40.8x 3.8x
INSP Unlock Forecast - 30 Days FREE Trial $2292M 43.2x 3.4x
IRMD Unlock Forecast - 30 Days FREE Trial $998M 48.3x 10.6x
IRTC Unlock Forecast - 30 Days FREE Trial $5807M -20.2x 56.0x
KIDS Unlock Forecast - 30 Days FREE Trial $398M -20.7x 1.1x
KMTS Unlock Forecast - 30 Days FREE Trial $1335M x x
KRMD Unlock Forecast - 30 Days FREE Trial $196M -19.8x 11.9x
LMAT Unlock Forecast - 30 Days FREE Trial $2043M 43.4x 5.6x
LNSR Unlock Forecast - 30 Days FREE Trial $143M -6.7x -7.0x
LUCD Unlock Forecast - 30 Days FREE Trial $130M -0.6x 16.6x
LUNG Unlock Forecast - 30 Days FREE Trial $62M -4.3x 0.9x
MCAG Unlock Forecast - 30 Days FREE Trial $33M x -9.6x
MCAGU Unlock Forecast - 30 Days FREE Trial $31M x -9.9x
MDNC Unlock Forecast - 30 Days FREE Trial $59M 26.2x 12.2x
MDXG Unlock Forecast - 30 Days FREE Trial $982M 30.5x 4.5x
MGRM Unlock Forecast - 30 Days FREE Trial $217M -10.7x 25.1x
MHUA Unlock Forecast - 30 Days FREE Trial $11M x 0.1x
MMM Unlock Forecast - 30 Days FREE Trial $90106M 26.8x 19.5x
MMSI Unlock Forecast - 30 Days FREE Trial $4900M 41.1x 3.3x
NEPH Unlock Forecast - 30 Days FREE Trial $52M 39.1x 6.2x
NMTC Unlock Forecast - 30 Days FREE Trial $41M -1.7x 5.0x
NPCE Unlock Forecast - 30 Days FREE Trial $346M -10.4x 17.8x
NSPR Unlock Forecast - 30 Days FREE Trial $74M -4.3x 3.6x
NVCR Unlock Forecast - 30 Days FREE Trial $1537M -20.8x 4.4x
NXGL Unlock Forecast - 30 Days FREE Trial $20M -6.8x 4.3x
OBIO Unlock Forecast - 30 Days FREE Trial $153M -3.4x 1.5x
OFIX Unlock Forecast - 30 Days FREE Trial $631M -5.8x 1.4x
OSRH Unlock Forecast - 30 Days FREE Trial $11M x 0.1x
OSUR Unlock Forecast - 30 Days FREE Trial $223M 17.1x 0.6x
PAVM Unlock Forecast - 30 Days FREE Trial $10M 0.1x 0.3x
PDEX Unlock Forecast - 30 Days FREE Trial $93M 10.3x 2.5x
PEN Unlock Forecast - 30 Days FREE Trial $9921M 67.4x 7.7x
PLRZ Unlock Forecast - 30 Days FREE Trial $6M x 0.3x
PMI Unlock Forecast - 30 Days FREE Trial $117M x x
PODD Unlock Forecast - 30 Days FREE Trial $22669M 97.8x 15.5x
PRCT Unlock Forecast - 30 Days FREE Trial $1945M -45.4x 5.0x
PROF Unlock Forecast - 30 Days FREE Trial $165M x 4.2x
PSTV Unlock Forecast - 30 Days FREE Trial $57M -0.3x 18.8x
PYPD Unlock Forecast - 30 Days FREE Trial $51M x 2.5x
RCEL Unlock Forecast - 30 Days FREE Trial $106M -5.0x -29.9x
RDGL Unlock Forecast - 30 Days FREE Trial $35M x 13.0x
RMD Unlock Forecast - 30 Days FREE Trial $38066M 27.7x 6.4x
RSMDF Unlock Forecast - 30 Days FREE Trial $3625M 2.6x 0.6x
RTGN Unlock Forecast - 30 Days FREE Trial $66M x x
RVP Unlock Forecast - 30 Days FREE Trial $27M -0.9x 0.4x
SGHT Unlock Forecast - 30 Days FREE Trial $275M -3.7x 3.9x
SIBN Unlock Forecast - 30 Days FREE Trial $666M -14.3x 3.9x
SKIN Unlock Forecast - 30 Days FREE Trial $176M -1.8x 2.4x
SNOA Unlock Forecast - 30 Days FREE Trial $6M -5.6x 1.6x
SNWV Unlock Forecast - 30 Days FREE Trial $265M x -19.4x
SOLV Unlock Forecast - 30 Days FREE Trial $12387M 32.9x 3.4x
SRTS Unlock Forecast - 30 Days FREE Trial $53M 31.6x 1.0x
SSKN Unlock Forecast - 30 Days FREE Trial $8M -8.0x 25.6x
STIM Unlock Forecast - 30 Days FREE Trial $206M -1.0x 7.6x
STME Unlock Forecast - 30 Days FREE Trial $20M x x
STSS Unlock Forecast - 30 Days FREE Trial $5M -2.5x 0.3x
SYK Unlock Forecast - 30 Days FREE Trial $147991M 50.7x 12.6x
TCMD Unlock Forecast - 30 Days FREE Trial $337M 22.3x 1.7x
TELA Unlock Forecast - 30 Days FREE Trial $61M -1.8x 6.6x
TFX Unlock Forecast - 30 Days FREE Trial $5952M 31.0x 1.4x
TNDM Unlock Forecast - 30 Days FREE Trial $1010M -17.1x 7.6x
TNON Unlock Forecast - 30 Days FREE Trial $9M -0.3x 1.4x
UFPT Unlock Forecast - 30 Days FREE Trial $1564M 44.7x 4.1x
USAQ Unlock Forecast - 30 Days FREE Trial $2M x x
UTMD Unlock Forecast - 30 Days FREE Trial $194M 15.5x 1.7x
VERO Unlock Forecast - 30 Days FREE Trial $4M 0.0x 1.8x
WST Unlock Forecast - 30 Days FREE Trial $21388M 44.4x 7.0x
XTNT Unlock Forecast - 30 Days FREE Trial $99M -478.8x 2.0x

Frequently Asked Questions - LEMAITRE VASCULAR INC Stock Forecast

How accurate are LEMAITRE VASCULAR INC stock predictions?

Our AI model shows a 63% Spearman correlation coefficient for LMAT predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence LEMAITRE VASCULAR INC stock price forecasts?

Our analysis considers LEMAITRE VASCULAR INC's financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is LEMAITRE VASCULAR INC a good investment in 2025?

Based on our AI analysis, LEMAITRE VASCULAR INC shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are LEMAITRE VASCULAR INC forecasts updated?

LEMAITRE VASCULAR INC stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced LEMAITRE VASCULAR INC Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for LEMAITRE VASCULAR INC stock.

My Portfolio

Investment Dashboard

Loading your portfolio...